Nonetheless, titin and RyR antibodies are invaluable prognostic biomarkers (10, 18).This indicates the complex roles of antibodies in MG, and the pressing need to unveil the underlying connections between these autoantibodies and the intricate array of clinical features. This evidence concerns the gene TTN and myasthenia gravis.